New Zealand markets closed

Cosmos Health Inc. (COSM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6741-0.0447 (-6.22%)
At close: 04:00PM EDT
0.6734 -0.00 (-0.10%)
After hours: 05:29PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 11.36M
Enterprise value 20.14M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.13
Price/book (mrq)0.26
Enterprise value/revenue 0.41
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 3.02
52-week change 3-78.33%
S&P500 52-week change 326.24%
52-week high 33.4180
52-week low 30.4680
50-day moving average 30.6643
200-day moving average 30.9656

Share statistics

Avg vol (3-month) 3109.2k
Avg vol (10-day) 3187.86k
Shares outstanding 516.85M
Implied shares outstanding 616.85M
Float 811.88M
% held by insiders 113.04%
% held by institutions 13.57%
Shares short (15 May 2024) 4332.19k
Short ratio (15 May 2024) 42.65
Short % of float (15 May 2024) 42.16%
Short % of shares outstanding (15 May 2024) 41.97%
Shares short (prior month 15 Apr 2024) 4444.83k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 321 Nov 2017
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 321 Nov 2017

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin -31.48%
Operating margin (ttm)-23.53%

Management effectiveness

Return on assets (ttm)-16.58%
Return on equity (ttm)-62.79%

Income statement

Revenue (ttm)49.59M
Revenue per share (ttm)5.07
Quarterly revenue growth (yoy)6.70%
Gross profit (ttm)N/A
EBITDA -15.34M
Net income avi to common (ttm)-42.91M
Diluted EPS (ttm)-4.2300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.38M
Total cash per share (mrq)0.18
Total debt (mrq)10.79M
Total debt/equity (mrq)24.20%
Current ratio (mrq)2.06
Book value per share (mrq)3.40

Cash flow statement

Operating cash flow (ttm)-26.91M
Levered free cash flow (ttm)-20.46M